International Assets Investment Management LLC Sells 116,257 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

International Assets Investment Management LLC reduced its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 98.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,314 shares of the exchange traded fund’s stock after selling 116,257 shares during the quarter. International Assets Investment Management LLC’s holdings in SPDR S&P Biotech ETF were worth $217,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently made changes to their positions in XBI. Avoro Capital Advisors LLC purchased a new position in SPDR S&P Biotech ETF in the fourth quarter valued at about $396,844,000. Healthcare of Ontario Pension Plan Trust Fund grew its stake in SPDR S&P Biotech ETF by 35.9% in the fourth quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 2,406,000 shares of the exchange traded fund’s stock valued at $214,832,000 after purchasing an additional 635,000 shares during the last quarter. Employees Retirement System of Texas purchased a new position in SPDR S&P Biotech ETF in the third quarter valued at about $27,456,000. Blackstone Inc. grew its stake in SPDR S&P Biotech ETF by 674.8% in the fourth quarter. Blackstone Inc. now owns 337,030 shares of the exchange traded fund’s stock valued at $30,093,000 after purchasing an additional 293,530 shares during the last quarter. Finally, MBB Public Markets I LLC grew its stake in SPDR S&P Biotech ETF by 67.0% in the third quarter. MBB Public Markets I LLC now owns 514,411 shares of the exchange traded fund’s stock valued at $37,562,000 after purchasing an additional 206,337 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI stock opened at $92.17 on Thursday. SPDR S&P Biotech ETF has a fifty-two week low of $63.80 and a fifty-two week high of $103.52. The firm has a market capitalization of $7.03 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The stock’s 50-day simple moving average is $89.57 and its 200-day simple moving average is $90.61.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.